基于数据挖掘的治疗抑郁症肝郁气滞型中药复方组方规律及作用机制的研究
Research on the Composition Rules and Mechanism of Traditional Chinese Medicine Formulas for Treating Depression of Liver Qi Stagnation Type Based on Data Mining
摘要: 目的:基于文献数据挖掘和网络药理学方法探索中药复方治疗肝郁气滞型抑郁的规律和可能机制。方法:收集中国知网、万方数据和维普三库自建库至今的相关文献。利用SPSS Modeler 18.0进行关联性分析和复杂网络分析,利用SPSS Statistics进行聚类分析,用药规律使用雷达图展示。检索TCMSP数据库获得关键中药的活性成分和靶点。利用GeneCards数据库获得抑郁症的靶点。对治疗靶点进行蛋白质–蛋白质相互作用分析、基因本体论(GO)和京都基因与基因组百科全书(KEGG)富集分析。结果:共收集中药复方治疗肝郁气滞型抑郁的相关文献18篇,涉及中药处方19首、中药67味,分析得到核心组分3个。分析核心组分柴胡、甘草和茯苓,得到80个活性成分,靶向65个抑郁症相关靶点。核心靶点为前列腺素氧化环化酶2 (Prostaglandin-Endoperoxide Synthase 2, PTGS2)、细胞凋亡调节因子(Apoptosis Regulator Bcl-2, BCL2)、信号转导和转录激活因子3 (Signal Transducer and Activator of Transcription 3, STAT3)、和雌激素受体1 (Estrogen Receptor 1, ESR1)。富集的通路有cGMP-PKG信号通路、胆碱能突触(Cholinergic Synapse)、钙信号通路(Calcium Signaling Pathway)、雌激素信号通路(Estrogen Signaling Pathway)等。结论:中药复方治疗肝郁气滞型抑郁以安神、补虚、清热为主。核心中药包含多成分,作用于多靶点和多通路。
Abstract: Objective: To explore the pattern and possible mechanism of Chinese herbal compound for treating depression of liver qi stagnation type based on literature data mining and network pharmacology methods. Methods: Relevant literature was collected from CNKI, Wanfang Data and VIP Library since the establishment of the library. Medication patterns were demonstrated using radar charts. Correlation analysis and complex network analysis were performed using SPSS Modeler 18.0 and cluster analysis was performed using SPSS Statistics. TCMSP database was searched to obtain the active ingredients and targets of key herbal medicines. GeneCards database was used to obtain targets for depression. The targets were analyzed by protein-protein interaction network construction, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment. Results: A total of 18 articles were collected from the literature related to the treatment of depression of liver qi stagnation type by Chinese herbal compound prescription, involving 19 Chinese herbal prescriptions and 67 Chinese herbal medicines, and three core components were obtained from the analysis. Analyzing the core components Radix Bupleuri, licorice and Poria Cocos (Schw.) Wolf., 80 active ingredients were obtained, targeting 65 depression-related targets. The core targets were prostaglandin-endoperoxide synthase 2 (PTGS2), apoptosis regulator Bcl-2 (BCL2), signal transducer and activator of transcription 3 (STAT3), and estrogen receptor 1 (ESR1). The enriched pathways were cGMP-PKG signalling pathway, Cholinergic synapse, Calcium signalling pathway and Estrogen signalling pathway. Conclusion: The treatment of depression of liver qi stagnation type by Chinese herbal compound is based on tranquilizing the spirit, tonifying deficiency and clearing heat. The core Chinese medicines contain multi-components and act on multi-targets and multi-pathways.
文章引用:曹诗雨, 金玥, 刘伯栋, 卢甜甜, 张奕珂. 基于数据挖掘的治疗抑郁症肝郁气滞型中药复方组方规律及作用机制的研究[J]. 计算生物学, 2025, 15(2): 13-24. https://doi.org/10.12677/hjcb.2025.152002

参考文献

[1] 陈启亮, 李灿东, 陈文婷, 等. 基于中医状态理论探讨抑郁症的精准辨识[J/OL]. 辽宁中医杂志, 1-8.
https://link.cnki.net/urlid/21.1128.R.20241105.1649.040, 2025-09-03.
[2] 谈荣珍, 章新友, 张玉娇, 等. 抑郁症的证型与体质及其关系的文献研究[J]. 江西中医药大学学报, 2019, 31(4): 32-36.
[3] 熊霞军, 胡志希, 钟森杰, 等. 基于数据挖掘的抑郁症中医证候分布及用药规律分析[J]. 中医药导报, 2020, 26(14): 148-151, 163.
[4] 谈荣珍. 抑郁症证型与体质关系及肝郁气滞型治疗方法的文献研究[D]: [硕士学位论文]. 南昌: 江西中医药大学, 2019.
[5] Singh, S., Meena, A.K., Sharma, G. and Deshpande, S.N. (2021) A Pilot Study on Effect of Adjunctive Transcranial Direct Current Stimulation on Symptom Domains of Depression in Patients with Depressive Disorder. Industrial Psychiatry Journal, 30, 305-309. [Google Scholar] [CrossRef] [PubMed]
[6] Shorey, S., Ng, E.D. and Wong, C.H.J. (2021) Global Prevalence of Depression and Elevated Depressive Symptoms among Adolescents: A Systematic Review and Meta‐Analysis. British Journal of Clinical Psychology, 61, 287-305. [Google Scholar] [CrossRef] [PubMed]
[7] COVID-19 Mental Disorders Collaborators (2021) Global Prevalence and Burden of Depressive and Anxiety Disorders in 204 Countries and Territories in 2020 Due to the COVID-19 Pandemic. The Lancet, 398, 1700-1712. [Google Scholar] [CrossRef
[8] Sampogna, G., Toni, C., Catapano, P., Rocca, B.D., Di Vincenzo, M., Luciano, M., et al. (2023) New Trends in Personalized Treatment of Depression. Current Opinion in Psychiatry, 37, 3-8. [Google Scholar] [CrossRef] [PubMed]
[9] Kverno, K.S. and Mangano, E. (2021) Treatment-Resistant Depression: Approaches to Treatment. Journal of Psychosocial Nursing and Mental Health Services, 59, 7-11. [Google Scholar] [CrossRef] [PubMed]
[10] 彭淑芹, 徐向东, 赵海霞. 四逆散对抑郁模型大鼠HPA轴、海马BDNF及其受体TrKB的影响[J]. 中国实验方剂学杂志, 2014, 20(5): 145-148.
[11] 李晓玲, 孙凤霞, 张燕洁. 解郁合欢汤加减治疗肝郁气滞型慢性乙型肝炎合并抑郁症的临床观察[J]. 中国中西医结合消化杂志, 2022, 30(6): 402-406.
[12] 朱亦诚. 柴胡加龙骨牡蛎汤治疗肝郁气滞型抑郁症临床疗效观察[D]: [硕士学位论文]. 南京: 南京中医药大学, 2020.
[13] 李珊珊. 解郁丸治疗中风后抑郁症肝郁气滞型的疗效观察[J]. 临床医药文献电子杂志, 2016, 3(30): 6083-6084.
[14] 李玉娟, 金星. 中医治疗抑郁症方药应用规律探析[J]. 河南中医, 2015, 35(1): 173-175.
[15] 张艺. 疏肝解郁法治疗阈下焦虑抑郁的用药规律及临床研究[D]: [硕士学位论文]. 北京: 北京中医药大学, 2020.
[16] 胡培豪, 张意笠, 钟晓明, 等. 中医药治疗抑郁组方用药规律研究[J]. 中药药理与临床, 2020, 36(6): 210-215.
[17] 曲艺, 崔向宁, 但文超, 等. 基于中医传承辅助平台挖掘中药复方专利中治疗抑郁的用药规律[J]. 世界科学技术:中医药现代化, 2022, 21(8): 1670-1675.
[18] 郑若韵, 贺娟, 熊为锋, 等. 静顺汤对抑郁模型大鼠行为学及海马单胺神经递质水平的影响[J]. 中医药导报, 2021, 27(1): 42-46.
[19] 王娟, 申丰铭, 张峥嵘, 等. 人参皂苷Rg1对慢性应激小鼠抑郁样行为,海马突触蛋白及胶质细胞的作用[J]. 生物学杂志, 2021, 38(3): 26-30.
[20] 盘晓芳. 基于GRADE体系的中药复方治疗抑郁症的系统评价[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2019.
[21] 孙锦锦. 肝郁气滞型抑郁症[J]. 家庭中医药, 2013(2): 60-61.
[22] 辛义周, 李宁, 高杰. 柴胡抗抑郁的药理机制研究进展[J]. 医学综述, 2013, 19(18): 3285-3287.
[23] 宗阳, 何书芬, 孙冰婷, 等. 甘草抗抑郁作用机制研究及应用概况[J]. 中国实验方剂学杂志, 2016, 22(10): 194-197.
[24] 黄世敬. 茯苓在治疗抑郁症中的应用[J]. 辽宁中医杂志, 2014, 41(2): 366-368.
[25] He, Y., Han, Y., Liao, X., Zou, M. and Wang, Y. (2022) Biology of Cyclooxygenase-2: An Application in Depression Therapeutics. Frontiers in Psychiatry, 13, Article 1037588. [Google Scholar] [CrossRef] [PubMed]
[26] Xiao, P., Zhang, X., Li, Y., Ma, Z., Si, S. and Gao, X. (2019) miR-9 Inhibition of Neuronal Apoptosis and Expression Levels of Apoptosis Genes Bcl-2 and Bax in Depression Model Rats through Notch Pathway. Experimental and Therapeutic Medicine, 19, 551-556. [Google Scholar] [CrossRef] [PubMed]
[27] Xu, K., Wang, M., Wang, H., Zhao, S., Tu, D., Gong, X., et al. (2024) HMGB1/STAT3/p65 Axis Drives Microglial Activation and Autophagy Exert a Crucial Role in Chronic Stress-Induced Major Depressive Disorder. Journal of Advanced Research, 59, 79-96. [Google Scholar] [CrossRef] [PubMed]
[28] Różycka, A., Słopień, R., Słopień, A., Dorszewska, J., Seremak-Mrozikiewicz, A., Lianeri, M., et al. (2016) The MAOA, COMT, MTHFR and ESR1 Gene Polymorphisms Are Associated with the Risk of Depression in Menopausal Women. Maturitas, 84, 42-54. [Google Scholar] [CrossRef] [PubMed]
[29] Zhou, X.Y., Zhang, F., Ying, C.J., Chen, J., Chen, L., Dong, J., et al. (2017) Inhibition of Inos Alleviates Cognitive Deficits and Depression in Diabetic Mice through Downregulating the NO/sGC/cGMP/PKG Signal Pathway. Behavioural Brain Research, 322, 70-82. [Google Scholar] [CrossRef] [PubMed]
[30] Inaba, H., Li, H., Kawatake-Kuno, A., Dewa, K., Nagai, J., Oishi, N., et al. (2023) GPCR-Mediated Calcium and cAMP Signaling Determines Psychosocial Stress Susceptibility and Resiliency. Science Advances, 9, eade5397. [Google Scholar] [CrossRef] [PubMed]
[31] Hwang, W.J., Lee, T.Y., Kim, N.S. and Kwon, J.S. (2020) The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders. International Journal of Molecular Sciences, 22, Article 373. [Google Scholar] [CrossRef] [PubMed]
[32] Srivastava, D.P., Woolfrey, K.M., Liu, F., Brandon, N.J. and Penzes, P. (2010) Estrogen Receptor Β Activity Modulates Synaptic Signaling and Structure. The Journal of Neuroscience, 30, 13454-13460. [Google Scholar] [CrossRef] [PubMed]